OMIC – singular genomics systems, inc. (US:NASDAQ)

News

Singular Genomics Systems, Inc. (NASDAQ: OMIC) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $0.85 to $0.75. They now have a "neutral" rating on the stock.
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results [Yahoo! Finance]
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
Labroots Announces the 12th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2024 [Yahoo! Finance]
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com